Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Johnson & johnson crawled time : 08:00 save search
Novo Holdings Joins €30M Series A Financing for Asgard Therapeutics, Leader In In Vivo Cell Reprogramming To Treat Cancer
Published: 2024-03-14 (Crawled : 08:00) - prnewswire.com
JNJ | News | $144.77 0.22% 0.22% 7.9M
|
Health Technology
|
| O: -1.04%
H: 0.0%
C: 0.0%
cancer treat series cell
Asgard Therapeutics announces €30 million Series A financing to advance its first-in-class in vivo cell reprogramming platform for immuno-oncology
Published: 2024-03-14 (Crawled : 08:00) - prnewswire.com
JNJ | News | $144.77 0.22% 0.22% 7.9M
|
Health Technology
|
| O: -1.04%
H: 0.0%
C: 0.0%
million series cell therapeutics platform
Appointment of new CEO
Published: 2024-03-13 (Crawled : 08:00) - globenewswire.com
JNJ | News | $144.77 0.22% 0.22% 7.9M
|
Health Technology
|
| O: 0.66%
H: 0.0%
C: 0.0%
ceo
Breakthrough 2024 Speaker Lineup Announced - Industry Experts to Discuss the Evolution of Life Sciences Through Technology, Automation, and Artificial Intelligence
Published: 2024-02-21 (Crawled : 08:00) - prnewswire.com
SNYNF | News | $92.7 0.63% -2.18% 1.4K
|
Health Technology
|
| O: 1.7%
H: 0.0%
C: 0.0%
JNJ | News | $144.77 0.22% 0.22% 7.9M
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: 0.0%
SNY | News | $46.11 0.68% 0.7% 3.5M
|
Health Technology
|
| O: -0.57%
H: 0.0%
C: 0.0%
intelligence life sciences
Virtualware Reports (MLVIR.PA) Record €4.52 Million Revenue in 2023, a 40% Surge from Previous Year
Published: 2024-01-24 (Crawled : 08:00) - globenewswire.com
AOMFF | $15.15 -5.61% 95.45% 9.2K
|
Producer Manufacturing
|
| O: -0.08%
H: 0.0%
C: 0.0%
ALSMY | $1.51 3.43% -1.78% 650K
|
Manufacturing
|
| O: -5.6%
H: 0.85%
C: -1.69%
JNJ | News | $144.77 0.22% 0.22% 7.9M
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
year million revenue
Clarivate Identifies Thirteen Potential Blockbuster Drugs and Gamechangers in Annual Drugs to Watch Report
Published: 2024-01-08 (Crawled : 08:00) - prnewswire.com
ALPMF | News | $9.594 1.2% 43.47% 0
|
Health Technology
|
| O: -0.85%
H: 1.05%
C: 0.08%
SNYNF | News | $92.7 0.63% -2.18% 1.4K
|
Health Technology
|
| O: 2.07%
H: 0.48%
C: 0.48%
ALPMY | News | $9.46 1.29% -1.11% 500K
|
Manufacturing
|
| O: 0.53%
H: 3.97%
C: 0.45%
CLVT | News | $6.91 1.77% 0.0% 3.9M
|
Information
|
| O: 0.92%
H: 6.4%
C: 5.03%
JNJ | News | $144.77 0.22% 0.22% 7.9M
|
Health Technology
|
| O: 0.47%
H: 0.0%
C: 0.0%
LLY | News | $750.77 0.54% 0.22% 2.8M
|
Health Technology
|
| O: 0.63%
H: 0.58%
C: 0.58%
SNY | News | $46.11 0.68% 0.7% 3.5M
|
Health Technology
|
| O: 1.16%
H: 0.0%
C: 0.0%
CALT | $18.74 5.29% 5.32% 6.8K
|
Health Technology
|
| O: 2.68%
H: 3.22%
C: 0.35%
report potential
Red Biotechnology Market to Reach $1,513.22 Billion, Globally, by 2030 at 10.7% CAGR: Coherent Market Insights
Published: 2023-12-08 (Crawled : 08:00) - prnewswire.com
ALPMF | News | $9.594 1.2% 43.47% 0
|
Health Technology
|
| O: -2.79%
H: 0.62%
C: 0.62%
SNYNF | News | $92.7 0.63% -2.18% 1.4K
|
Health Technology
|
| O: 2.06%
H: 0.82%
C: 0.82%
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: -1.29%
H: 0.4%
C: 0.4%
ALPMY | News | $9.46 1.29% -1.11% 500K
|
Manufacturing
|
| O: -2.2%
H: 0.0%
C: -0.27%
TAK | $13.15 -0.61% 0.0% 1.5M
|
Health Technology
|
| O: -0.64%
H: 0.5%
C: 0.5%
NVO | News | $124.53 0.88% 0.19% 2.5M
|
Health Technology
|
| O: -0.42%
H: 0.67%
C: 0.25%
NVS | News | $93.08 -0.13% 0.13% 1.1M
|
Health Technology
|
| O: 0.19%
H: 0.35%
C: 0.2%
JNJ | News | $144.77 0.22% 0.22% 7.9M
|
Health Technology
|
| O: -0.18%
H: 0.0%
C: 0.0%
LLY | News | $750.77 0.54% 0.22% 2.8M
|
Health Technology
|
| O: 0.43%
H: 0.0%
C: 0.0%
BMY | $47.84 -0.87% 0.82% 9.9M
|
Health Technology
|
| O: 0.2%
H: 0.55%
C: 0.1%
ABBV | $164.25 1.05% -0.76% 4M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
SNY | News | $46.11 0.68% 0.7% 3.5M
|
Health Technology
|
| O: 1.07%
H: 0.0%
C: 0.0%
GILD | $66.93 -0.57% -0.55% 3.8M
|
Health Technology
|
| O: 0.08%
H: 1.45%
C: 1.17%
AMGN | $264.07 -0.59% -0.59% 1.6M
|
Health Technology
|
| O: -0.05%
H: 0.3%
C: -0.76%
reach market
Samsung Bioepis Secures US License Date for SB17, a Proposed Biosimilar to Stelara®
Published: 2023-11-30 (Crawled : 08:00) - biospace.com/
JNJ | News | $144.77 0.22% 0.22% 7.9M
|
Health Technology
|
| O: 0.6%
H: 1.89%
C: 1.58%
sb17 stelara biosimilar license
Striving Together For A Thriving Industry, International Biopharma Industry Week Shanghai 2023 Opens
Published: 2023-10-20 (Crawled : 08:00) - prnewswire.com
SNYNF | News | $92.7 0.63% -2.18% 1.4K
|
Health Technology
|
| O: -3.95%
H: 0.0%
C: -0.72%
JNJ | News | $144.77 0.22% 0.22% 7.9M
|
Health Technology
|
| O: 0.47%
H: 0.0%
C: 0.0%
SNY | News | $46.11 0.68% 0.7% 3.5M
|
Health Technology
|
| O: -0.17%
H: 0.0%
C: 0.0%
international biopharma week
Alvotech Provides Update on Status of U.S. Biologics License Application for AVT04
Published: 2023-10-12 (Crawled : 08:00) - globenewswire.com
ALVO | $12.8 0.55% 0.31% 130K
|
n/a
|
| O: -0.22%
H: 0.0%
C: -0.66%
JNJ | News | $144.77 0.22% 0.22% 7.9M
|
Health Technology
|
| O: -1.87%
H: 0.0%
C: 0.0%
KMDA | $5.08 3.67% 5.77% 34K
|
Health Technology
|
| O: -0.51%
H: 0.1%
C: -1.32%
avt04 license update application
Royalty Pharma and Ferring Pharmaceuticals Enter into US $500 million Royalty Agreement for New Intravesical Gene Therapy Adstiladrin® (nadofaragene firadenovec-vncg)
Published: 2023-08-24 (Crawled : 08:00) - biospace.com/
JNJ | News | $144.77 0.22% 0.22% 7.9M
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: 0.0%
RPRX | News | $27.61 0.55% 0.58% 1.9M
|
Health Technology
|
| O: 0.0%
H: 0.72%
C: -0.4%
adstiladrin pharma pharmaceuticals royalty agreement therapy
Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership
Published: 2023-07-24 (Crawled : 08:00) - globenewswire.com
ALVO | $12.8 0.55% 0.31% 130K
|
n/a
|
| O: 5.05%
H: 2.26%
C: -3.17%
JNJ | News | $144.77 0.22% 0.22% 7.9M
|
Health Technology
|
| O: 0.77%
H: 1.35%
C: -0.24%
KMDA | $5.08 3.67% 5.77% 34K
|
Health Technology
|
| O: -0.59%
H: 1.18%
C: -0.97%
partnership update pharmaceuticals teva
Mestag Therapeutics and VIB enter into an exclusive partnership in oncology
Published: 2023-06-27 (Crawled : 08:00) - prnewswire.com
JNJ | News | $144.77 0.22% 0.22% 7.9M
|
Health Technology
|
| O: 0.03%
H: 0.12%
C: -0.24%
partnership therapeutics
FY 2022 Integrated Report
Published: 2023-03-16 (Crawled : 08:00) - aspenpharma.com
JNJ | News | $144.77 0.22% 0.22% 7.9M
|
Health Technology
|
| O: -0.58%
H: 0.6%
C: 0.38%
report
Mild Cognitive Impairment (MCI) Treatment Market to Experience Substantial CAGR Growth of 8.7% by 2029, Size, Share, Trends, Key Drivers, Growth and Opportunity Analysis
Published: 2023-02-16 (Crawled : 08:00) - prnewswire.com
UCBJY | $63.31 -4.38% 9.4K
|
Manufacturing
|
| O: -1.68%
H: 0.0%
C: -0.76%
VTRS | $11.095 -0.22% -0.23% 6.1M
|
Health Technology
|
| O: -1.1%
H: 0.21%
C: -0.6%
TAK | $13.15 -0.61% 0.0% 1.5M
|
Health Technology
|
| O: -0.89%
H: 0.71%
C: 0.26%
NVS | News | $93.08 -0.13% 0.13% 1.1M
|
Health Technology
|
| O: -1.48%
H: 0.55%
C: 0.08%
JNJ | News | $144.77 0.22% 0.22% 7.9M
|
Health Technology
|
| O: -0.19%
H: 0.36%
C: -0.52%
treatment growth market
EMA Confirms Acceptance of Application for AVT04, a Proposed Biosimilar to Stelara® (ustekinumab)
Published: 2023-02-09 (Crawled : 08:00) - globenewswire.com
ALVO | $12.8 0.55% 0.31% 130K
|
n/a
|
| O: 7.61%
H: 0.0%
C: -4.64%
JNJ | News | $144.77 0.22% 0.22% 7.9M
|
Health Technology
|
| O: 0.01%
H: 0.71%
C: -1.36%
KMDA | $5.08 3.67% 5.77% 34K
|
Health Technology
|
| O: -0.23%
H: 0.25%
C: -2.05%
avt04 stelara biosimilar ema application
Animal wound care Market Size by Product (Surgical Staplers, Surgical Sutures, Automated Suturing Devices, Surgical Sealants and Adhesives), By Application (Retail, E-Commerce, Veterinary Hospital and Clinic), Global Trends and Forecast till 2029
Published: 2023-02-02 (Crawled : 08:00) - prnewswire.com
JNJ | News | $144.77 0.22% 0.22% 7.9M
|
Health Technology
|
| O: -1.16%
H: 1.98%
C: 1.56%
MMM | $90.96 -0.1% 0.39% 2.9M
|
Producer Manufacturing
|
| O: 0.2%
H: 4.1%
C: 3.62%
NEOG P 10000 | $12.14 -0.16% -0.16% 3.1M
|
Health Technology
|
| O: 1.49%
H: 1.46%
C: -0.38%
care veterinary global trends application animal market
Bronwyn Brophy is appointed new CEO of Vitrolife AB (publ)
Published: 2023-02-01 (Crawled : 08:00) - prnewswire.com
JNJ | News | $144.77 0.22% 0.22% 7.9M
|
Health Technology
|
| O: -0.26%
H: 1.83%
C: 1.18%
ceo
Bavarian Nordic Enters Agreement Valued up to USD 83 Million with the U.S. Department of Defense to Further Advance the Development of Equine Encephalitis Virus Vaccine
Published: 2022-12-23 (Crawled : 08:00) - globenewswire.com
JNJ | News | $144.77 0.22% 0.22% 7.9M
|
Health Technology
|
| O: -0.2%
H: 0.48%
C: 0.46%
defense vaccine virus agreement
SciBase Interim report
Published: 2022-11-10 (Crawled : 08:00) - prnewswire.com
JNJ | News | $144.77 0.22% 0.22% 7.9M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
report
Gainers vs Losers
| 57% | 43% |
Top 10 Gainers
INVO | $1.82 139.47% 56.82% 220M
|
Health Technology
SINT | $0.0373 62.88% 37.26% 460M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.66 46.37% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 600K
|
Manufacturing
TCON | $2.29 33.92% 26.61% 1.8M
|
Health Technology
TIRX | $0.4848 7.49% 24.58% 5.9M
|
SRFM 4 | $0.3859 -12.3% 23.84% 660K
|
n/a
KZIA | $0.3442 18.28% 23.42% 290K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.